In obstetric patients, the incidence of pruritus after epidural or intrathecal administration of hydrophilic opioids such as morphine is frequent and may limit their use
(6). This vulnerability to pruritus, thought to be caused by the altered binding of opioids at receptor sites, may be caused by competition by estrogens
(7). The increased cephalad spread of spinally administered drugs in a pregnant woman at term as compared with the general population may also play a role
(8). This study demonstrated a 35% incidence of intrathecal morphine-induced pruritus requiring treatment (pruritus score
3), and this is consistent with previously reported values (
5,
9,
10). The parturients were observed for four hours in the postanesthesia care unit, because pruritus usually occurs within a few hours of intrathecal morphine injection (
11,
12). The onset of pruritus in this study ranged from 25 to 180 minutes, which is also consistent with the previous results
(10).
The mechanism of pruritus after the neuraxial administration of opioids is not fully understood. It is probably not related to histamine release, because histamine blockers are ineffective in the therapy of pruritus caused by spinal morphine
(13). Another theory is that the opioid receptors in the central nervous system are activated by morphine. Opioid receptors are located both supraspinally and at the spinal cord level. Spinal opioids activate the opioid receptors in the substantia gelatinosa of the spinal cords dorsal horn
(14). The µ receptor is responsible for pain modulation and some side effects, especially pruritus
(14). This would explain the antipruritic effect of nalbuphine or naloxone, specific µ antagonists (
3,
5). A third theory is that the pruritus from neuraxial opioids may be related to the excitatory effects of opioids on the nocifensive and nonnocifensive neurons in the anterior and posterior spinal horns
(15). Propofol may relieve pruritus related to neuraxial opioids because it has an inhibitory effect on the dorsal horn of the spinal cord
(15). Recently, there has been evidence that opioids and the serotoninergic system interact closely in the central nervous system; ondansetron, a specific 5-hydroxytryptamine-3 receptor antagonist, has an antipruritic effect (
10,
16).